Search Results For ''

  • Race Oncology Secures Ethics Approval for RC220 Solid Tumour Trial

    Ethics Approval Clears Path for RC220 Clinical Trial Race Oncology (ASX:RAC) has received a major regulatory green light, with the Bellberry Human Research Ethics Committee (HREC) granting approval for its Phase 1 clinical trial of RC220 in combination with doxorubicin for solid tumour patients. This milestone enables the lead site, Southside Cancer Care Centre in

    Read More
    Public
  • Proteomics International Launches PromarkerD to Tackle Australia’s Diabetes Crisis

    Predictive Test Aims to Revolutionise Kidney Disease Management Australia’s healthcare system is facing a growing challenge: diabetes-related kidney disease. With over 1.3 million Australians living with diabetes, more than half are at risk of developing chronic kidney disease (DKD), a leading cause of dialysis and kidney failure. In a significant step forward, Proteomics International Laboratories

    Read More
    Public
  • BlinkLab Kicks Off U.S. Autism Diagnostic Study with First Patient Tested

    Addressing Critical Gaps in Autism Diagnosis Autism spectrum disorder (ASD) affects millions of children worldwide, yet early diagnosis remains a major challenge. Despite recommendations from the American Academy of Paediatrics (AAP) for autism screening at 18 and 24 months, many children experience delays in diagnosis, missing the crucial window for early intervention. BlinkLab Limited (ASX:BB1)

    Read More
    Public
  • Wide Open Agriculture Expands Global Footprint with New Sales in Europe, Latin America & Australia

    Lupin Protein Gains Global Momentum Wide Open Agriculture (ASX:WOA) is making significant strides in the global plant-based protein market, securing initial commercial sales and purchase orders across five continents. This latest development highlights the growing demand for WOA’s lupin protein isolates, and positions the company as a key player in the alternative protein sector. “These

    Read More
    Public
  • Hillgrove Hits Record Copper Production in February

    Kanmantoo’s Output Surges as Operations Strengthen Hillgrove Resources (ASX:HGO) has delivered a record-breaking month at its Kanmantoo Copper Mine, producing 1,105 tonnes of copper in February 2025. This marks the highest monthly production since the site began processing underground material in February 2024, reinforcing the mine’s steady operational improvement. CEO Highlights Operational Gains Hillgrove CEO

    Read More
    Public
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium

    One of the world’s largest manufacturers of power supply units has identified an investment opportunity in Australia through a $1.5 million investment made in eCommerce company Harris Technology (ASX: HT8) at a substantial premium to their share price.  The investment by FSP Technology was completed through a private Placement at an issue price of 2

    Read More
    Public